What was the main things that you wanted to find?

Yeah, so a little bit of background.

The SUMMIT trial followed the STEP-HEF-PEF trial.

So there was a secondary analysis of many of the diabetes studies that showed there was reduced heart failure events.

in diabetics with HFPEF.

And then the STEP HFPEF trial was a study of semaglutide in heart failure with preserved ejection fraction, or HFPEF.

And what the STEP HFPEF studies showed was, and the primary endpoint was exercise capacity and how patients felt as measured by the Kansas City Heart Failure Questionnaire, or KCCQ.

But of course, from what you've told us so far, it seems to be more on effects, well, on fat pads around the